eFFECTOR Therapeutics (EFTR) Institutional Ownership → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free EFTR Stock Alerts $2.03 -0.11 (-5.14%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for eFFECTOR Therapeutics (NASDAQ:EFTR)CurrentInstitutional OwnershipPercentage57.67%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$2.03MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$70.86M Get EFTR Insider Trade Alerts Want to know when executives and insiders are buying or selling eFFECTOR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EFTR Institutional Buying and Selling by Quarter Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. eFFECTOR Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/3/2024 Carlyle Group Inc.192,884$2.72M0.2%-96.0%5.227% 11/13/2023Column Group LLC4,026,224$2.42M1.6%-6.6%9.496% 11/2/2023Sonora Investment Management Group LLC125,000$75K0.0%N/A0.295% 6/5/2023EP Wealth Advisors LLC17,607$1.65M0.0%N/A0.042% 5/5/2023 Carlyle Group Inc.4,822,114$1.69M0.1%N/A11.373% 8/16/2022 Callan Capital LLC20,000$28K0.0%N/A0.048% 8/2/2022Resolute Financial LLC30,000$43K0.0%N/A0.072% 8/1/2022 Parallel Advisors LLC1,693,559$2.41M0.1%+150.0%4.092% 4/28/2022 Parallel Advisors LLC677,452$2.74M0.1%N/A1.637% 2/15/2022SR One Capital Management LP6,822,114$56.49M31.9%N/A16.898% 2/9/2022Alps Advisors Inc.51,942$430K0.0%N/A0.129% 2/3/2022OUP Management Co. LLC1,025,697$8.49M3.8%N/A2.541% 11/16/2021Verition Fund Management LLC24,667$347K0.0%N/A0.061% 11/15/2021Abingworth LLP4,822,114$67.03M15.2%N/A11.964% 11/15/2021Sectoral Asset Management Inc2,882,744$40.50M3.4%N/A7.153% (Data available from 1/1/2016 forward) EFTR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EFTR shares? During the previous two years, the following institutional investors and hedge funds held shares of eFFECTOR Therapeutics shares: Carlyle Group Inc. ($2.72M), Column Group LLC ($2.42M), Parallel Advisors LLC ($2.41M), EP Wealth Advisors LLC ($1.65M), Sonora Investment Management Group LLC ($75K), and Resolute Financial LLC ($43K), and Callan Capital LLC ($28K).Learn more on EFTR's institutional investors. What percentage of eFFECTOR Therapeutics stock is owned by institutional investors? 57.67% of eFFECTOR Therapeutics stock is owned by institutional investors. Learn more on EFTR's institutional investor holdings. Which institutional investors have been buying eFFECTOR Therapeutics stock? The following institutional investors have purchased eFFECTOR Therapeutics stock in the last 24 months: Carlyle Group Inc. ($4.82M), Parallel Advisors LLC ($1.02M), Sonora Investment Management Group LLC ($125K), Resolute Financial LLC ($30K), Callan Capital LLC ($20K), and EP Wealth Advisors LLC ($17.61K). How much institutional buying is happening at eFFECTOR Therapeutics? Institutional investors have bought a total of 6,030,828 shares in the last 24 months. This purchase volume represents approximately $82.40M in transactions. Which eFFECTOR Therapeutics major shareholders have been selling company stock? The following institutional investors have sold eFFECTOR Therapeutics stock in the last 24 months: Carlyle Group Inc. ($4.63M), and Column Group LLC ($283.11K). How much institutional selling is happening at eFFECTOR Therapeutics? Institutional investors have sold a total of 4,912,335 shares in the last 24 months. This volume of shares sold represents approximately $70.86M in transactions. Related Companies: Vaccinex Major Shareholders Hepion Pharmaceuticals Major Shareholders Cyclerion Therapeutics Major Shareholders Can-Fite BioPharma Major Shareholders Bionomics Major Shareholders Virios Therapeutics Major Shareholders Cadrenal Therapeutics Major Shareholders Processa Pharmaceuticals Major Shareholders TransCode Therapeutics Major Shareholders Trevena Major Shareholders This page (NASDAQ:EFTR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
